K-Stat 500mg Tablet contains Ethamsylate 500mg, an effective hemostatic agent used to reduce bleeding by promoting capillary endothelial stability and enhancing platelet adhesion. It is primarily indicated for the prevention and treatment of bleeding in various clinical conditions such as menorrhagia, postoperative hemorrhage, capillary fragility, and hemorrhagic disorders associated with surgery or trauma. Ethamsylate acts by improving platelet function and restoring capillary resistance, thereby reducing excessive bleeding without affecting coagulation parameters significantly. K-Stat 500mg is commonly administered orally, with dosage tailored according to the severity of bleeding and patient response. It is well tolerated, with minimal adverse effects, though occasional gastrointestinal discomfort or allergic reactions may occur. Caution is advised in patients with known hypersensitivity to Ethamsylate or related compounds. It should be used under medical supervision, particularly in individuals with coagulation abnormalities or those on anticoagulant therapy. K-Stat 500mg Tablet offers a valuable therapeutic option in managing hemorrhagic conditions by effectively controlling bleeding and supporting hemostasis, contributing to improved patient outcomes in both acute and chronic bleeding scenarios.